Cited by 45

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment

Bao, Hong, Liu, Yiming, Zhang, Mengguo, Chen, Zuolong, Zhang, Weiwei, Ge, Yuhao, Kang, Dongmei, Gao, Feng, Shen, Yong·2021·Alzheimer's & Dementia

Abstract

Introduction: Patients with type 2 diabetes mellitus (T2DM) are at a high risk of cognitive impairment, with insulin resistance playing a pivotal role. β‐site amyloid precursor protein cleaving enzyme 1 (BACE1) is considered a predictor of Alzheimer's disease. However, the potential roles of BACE1 in insulin resistance and the risk of cognitive impairment in T2DM remain unclear. Methods: We measured plasma BACE1 levels, BACE1 cleavage activities for Swedish mutant amyloid precursor protein (APPsw) and insulin receptor β subunit (INSR‐β), and soluble INSR (sINSR) levels in a clinical cohort study. Results: T2DM patients with or without cognitive impairment exhibited elevated plasma BACE1 levels and BACE1 enzymatic activities for APPsw and INSR‐β, and sINSR levels. Moreover, the glycemic status correlated with elevated BACE1 levels and BACE1‐mediated INSR cleavage, which was associated with insulin resistance. Discussion: The elevated BACE1 levels in T2DM may contribute to increasing the cognitive impairment risk through both amyloidogenesis and insulin resistance.

Overview

Integrity signals

Registry

Crossref · 10.1002/alz.12276

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Plasma BACE1 protein levels are elevated in people with T2D and correlate with glycemic control, independently of cognition.

    “Furthermore, plasma BACE1 protein levels are elevated in people with T2D and correlate with glycemic control, independently of cognition.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [192]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. 10.1038/emm.2015.3 · DOI
  2. 10.1001/archneur.62.7.1067 · DOI
  3. 10.1038/nrendo.2010.228 · DOI
  4. 10.1016/S2213-8587(13)70192-X · DOI
  5. 10.1038/nm.4350 · DOI · Paper page
  6. 10.1038/nrdp.2015.19 · DOI · Paper page
  7. 10.1038/s41574-018-0048-7 · DOI · Paper page
  8. 10.1038/nrn4019 · DOI
  9. 10.1172/JCI57256 · DOI
  10. 10.1136/bmj.315.7115.1045 · DOI
  11. 10.1007/s00401-014-1328-5 · DOI
  12. 10.3233/JAD-141791 · DOI · Paper page
  13. 10.2337/dc13-1672 · DOI
  14. Hampel H, 2020, The beta‐Secretase BACE1 in Alzheimer's, Disease Biol Psychiatry
  15. 10.1038/990114 · DOI · Paper page
  16. 10.1038/990107 · DOI · Paper page
  17. 10.1016/S1474-4422(13)70276-X · DOI
  18. 10.1016/j.jalz.2019.07.001 · DOI · Paper page
  19. 10.1016/j.biopsych.2017.02.007 · DOI · Paper page
  20. 10.1177/0271678X15606463 · DOI · Paper page
  21. 10.1038/s41467-018-03755-2 · DOI · Paper page
  22. 10.1016/j.pneurobio.2006.06.001 · DOI
  23. 10.1523/JNEUROSCI.3657-09.2009 · DOI · Paper page
  24. 10.1001/archneurol.2010.225 · DOI · Paper page
  25. 10.2337/ds16-0041 · DOI
  26. 10.1016/S2213-8587(13)70088-3 · DOI
  27. 10.1210/er.2017-00073 · DOI
  28. 10.1172/jci.insight.95107 · DOI
  29. 10.1111/cns.12866 · DOI
  30. 10.1016/j.tins.2016.01.003 · DOI · Paper page
  31. 10.15252/emmm.201404438 · DOI · Paper page
  32. 10.1016/j.brainresbull.2016.04.009 · DOI · Paper page
  33. 10.1146/annurev.med.46.1.223 · DOI · Paper page
  34. Apicella M, 2020, COVID‐19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabetes Endocrinol, 46, 782, 10.1016/S2213-8587(20)30238-2 · DOI
  35. 10.2337/dc20-0598 · DOI
  36. 10.3389/fnagi.2017.00399 · DOI
  37. 10.3389/fnins.2018.00930 · DOI
  38. Kellar D, 2020, Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches, Lancet Neurol
  39. 10.1172/JCI99366 · DOI
  40. 10.1016/j.cell.2016.07.028 · DOI
  41. 10.1073/pnas.1710625114 · DOI
  42. 10.1212/WNL.0000000000000403 · DOI
  43. 10.1186/1742-2094-8-150 · DOI
  44. 10.2337/dc13-0610 · DOI

Cited by

Sorted by citations

Metadata

Authors
Bao, H., Liu, Y., Zhang, M., Chen, Z., Zhang, W., Ge, Y., Kang, D., Gao, F., & Shen, Y.
Affiliations
  • Neurodegenerative Disorder Research Center Division of Life Sciences and Medicine University of Science and Technology of China Hefei China
  • Institute on Aging and Brain Disorders First Affiliated Hospital of University of Science and Technology of China Hefei China
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2021-01-07
Volume
17
Issue
7
Pages
1097-1108
ISSN
  • 1552-5260
  • 1552-5279
Cited by
45
References
4
Language
en
Funders
Chinese Academy of Sciences (QYZDY‐SSW‐SMC012, XDB39000000)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review